Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05253872 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The MELAcare Study: A New Method for Surveillance of Melanoma Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 26, 2023 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Mar 2025 to Jun 2024v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2022 to Mar 9, 2022
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate a new method of follow-up for patients with low and intermediate risk (stages IA-IIA) melanoma. The investigators will compare different tools for patient support and education combined with clinician supported skin self-examination (SSE) to the current standard-of-care. The hypothesis is that meta-cognitive strategies and clinician supported SSE can lower fear of cancer recurrence (FCR) and promote effective SSE on a regular basis without compromising the detection of new primary melanomas and/or metastases.
Trial Details
NCT Number NCT05253872
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: Danish Cancer Society
Conditions
(from sponsor)		 Cutaneous Melanoma
Related terms Melanoma
Enrollment 378 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov